Effectiveness of Messages to Mobile Phone in Smoke Cessation
- Conditions
- Smoking
- Registration Number
- NCT01746069
- Lead Sponsor
- Basque Health Service
- Brief Summary
Smoking remains a major risk factor for chronic diseases and is a real problem for health systems. The use of emerging technologies, such as mobile phone , may have a important role in smoking cessation programs through sending reinforcement messages when patients quits smoking.
Main objective: To evaluate the effectiveness of a combined 6 months smoking cessation program including health advice provided by a doctor and sending support messages to mobile phone of patients.
Methods: Study design: Randomized single blind clinical trial. Study population: Patients over 18 who are willing to start a smoking cessation program, who have mobile phone, who are able to receive and send messages, and who have a score greater than 5 or equal to 5 on the Richmond scale.
Sample size: 160 patients per arm to detect a difference in the percentage of smoking cessation than 10% (14.9% vs. 4.9%) between the two groups. Intervention: Experimental group: Health advice and support messages to mobile phone patients.
Control group: Health advice. Assessment of the primary endpoint: At 6 months (positive/negative coximetry test).
Statistical analysis: The analysis of the primary endpoint (positive / negative coximetry test) will be performed using logistic regression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 320
- Over 18 years.
- Current smoker (25): Current smoker is defined as the person who at the time of the study beginning declares that smoked daily or occasionally.
- Possessing mobile phone.
- Able to receive and send messages through mobile phone.
- Score greater than 5 or equal to 5 on the Richmond scale
Exclusion criteria:
- People with a history of mental and behavioral disorders.
- Patients with a diagnosis of depression using the depression subscale of Goldberg (two or more positive responses).
- Patients who with pharmacological therapy for smoking cessation or who require it throughout the study.
- Pregnant women.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Coximetry test (positive/negative) at 6 months
- Secondary Outcome Measures
Name Time Method Number of messages requested by the patient anxiety. at 12 months -Prevalence abstinence at the 4th week self-reported by the patient: Yes / No. At 4th week Number of messages relapse-slip timely requested by the patient. At 12 months slip: Yes / No. at 12 months Treated as the first use (consumption point) after a period of abstinence
-Outcome of coxymetry test at 12 months of start: Positive / Negative. at 12 months Only in patients with a negative result in the 6 months test
- Relapse: Yes / No. At 12 months Relapse is defined to return dependent behavior that had tried to change, recovering or not the baseline levels before treatment.
Continuous abstinence at 6 months: Yes / No At 6 months Continuous Abstinence is defined as smoking more than 5 cigarettes since the beginning of the follow-up period self-reported by the patient.
Abstinence point during the first 7 days self-reported by the patient: Yes / No. at first week Abstinence is defined as not smoking anything punctual during the last seven days.
-Prevalence abstinence at 12th week self-reported by the patient: Yes / No. At 12th week
Trial Locations
- Locations (1)
Health centre Lakuabizkarra
🇪🇸Vitoria-Gasteiz, Alava, Spain
Health centre Lakuabizkarra🇪🇸Vitoria-Gasteiz, Alava, Spain